| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Walter Huber | |
| Francis Mueller | |||
| P4510 | describes a project that uses | surface plasmon resonance | Q898756 |
| P433 | issue | 31 | |
| P921 | main subject | surface plasmon resonance | Q898756 |
| drug discovery | Q1418791 | ||
| P304 | page(s) | 3999-4021 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology | |
| P478 | volume | 12 |
| Q35081931 | A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding |
| Q24316275 | Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites |
| Q50563557 | Binding of EGF1 domain peptide in coagulation factor VII with tissue factor and its implications for the triggering of coagulation. |
| Q37610874 | Binding of small molecules at interface of protein-protein complex - A newer approach to rational drug design. |
| Q36102317 | Biophysics in drug discovery: impact, challenges and opportunities. |
| Q38665514 | Biophysics: for HTS hit validation, chemical lead optimization, and beyond |
| Q37108161 | Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding |
| Q34086865 | Cellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor |
| Q95404254 | Characterization of drug-protein interactions by capillary electrophoresis hyphenated to mass spectrometry |
| Q48309880 | Confirming therapeutic target of protopine using immobilized β2 -adrenoceptor coupled with site-directed molecular docking and the target-drug interaction by frontal analysis and injection amount-dependent method |
| Q38339048 | Development of biosensor-based assays to identify anti-infective oligosaccharides |
| Q47400739 | Elucidation of direct competition and allosteric modulation of small-molecular-weight protein ligands using surface plasmon resonance methods |
| Q34049517 | Emerging role of surface plasmon resonance in fragment-based drug discovery. |
| Q40156549 | Exploitation of SPR to Investigate the Importance of Glycan Chains in the Interaction between Lactoferrin and Bacteria |
| Q26826945 | Fragment screening and HIV therapeutics |
| Q38300142 | Inhibition of P-fimbriated Escherichia coli adhesion by multivalent galabiose derivatives studied by a live-bacteria application of surface plasmon resonance. |
| Q33852386 | Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process. |
| Q41943527 | Label-enhanced surface plasmon resonance: a new concept for improved performance in optical biosensor analysis |
| Q33782666 | Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors. |
| Q43811068 | Modern surface plasmon resonance for bioanalytics and biophysics |
| Q36012336 | Native serotonin membrane receptors recognize 5-hydroxytryptophan-functionalized substrates: enabling small-molecule recognition. |
| Q38098433 | Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches |
| Q92192845 | Proteomics and Non-proteomics Approaches to Study Stable and Transient Protein-Protein Interactions |
| Q50086778 | Quantitative monitoring of two simultaneously binding species using Label-Enhanced surface plasmon resonance. |
| Q82605079 | Rapid determination of protein binding constant by a pressure-mediated affinity capillary electrophoresis method |
| Q46144714 | Rapid ultrasensitive measurement of salivary cortisol using nano-linker chemistry coupled with surface plasmon resonance detection |
| Q35231270 | Repositioning the substrate activity screening (SAS) approach as a fragment-based method for identification of weak binders |
| Q36373199 | SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands |
| Q36307546 | Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics |
| Q38333995 | Synthesis of a new class of ribose functionalized dinucleotide cap analogues for biophysical studies on interaction of cap-binding proteins with the 5' end of mRNA. |
| Q37010408 | Systems biology and cancer stem cells |
| Q33852396 | Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. |
| Q35687836 | Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? |
| Q38784547 | Tracking of STAT3 signaling for anticancer drug-discovery based on localized surface plasmon resonance |
| Q26859238 | Trends in protein-based biosensor assemblies for drug screening and pharmaceutical kinetic studies |
| Q33381173 | Update of KDBI: Kinetic Data of Bio-molecular Interaction database. |
| Q39003007 | Use of surface plasmon resonance in the binding study of vitamin D, metabolites and analogues with vitamin D binding protein |
Search more.